$1.11
-0.07 (-5.56%)
Open$1.18
Previous Close$1.17
Day High$1.18
Day Low$1.05
52W High$3.61
52W Low$0.55
Volume—
Avg Volume203.0K
Market Cap5.91M
P/E Ratio—
EPS$-1.36
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+3,849.3% upside
Current
$1.11
$1.11
Target
$43.64
$43.64
$27.68
$43.64 avg
$53.21
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.63M | 2.80M | 1.47M |
| Net Income | -10,423,783 | -7,238,179 | 533.2K |
| Profit Margin | -287.4% | -273.0% | 36.3% |
| EBITDA | -10,440,367 | -7,652,456 | 838.1K |
| Free Cash Flow | — | — | 521.2K |
| Rev Growth | +29.6% | +29.6% | +11.3% |
| Debt/Equity | 0.02 | 0.02 | 0.46 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |